Receive News & Ratings for Merit Medical Systems Daily

Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.

Financial Review: Merit Medical Systems (MMSI) & Its Peers

Merit Medical Systems (NASDAQ: MMSI) is one of 106 publicly-traded companies in the “Surgical & medical instruments” industry, but how does it compare to its rivals? We will compare Merit Medical Systems to similar businesses based on the strength of its risk, valuation, analyst recommendations, earnings, profitability, dividends and institutional ownership.

Receive News & Ratings for Merit Medical Systems Daily

Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.

Valuation and Earnings

This table compares Merit Medical Systems and its rivals gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Merit Medical Systems $727.85 million $27.52 million 40.23
Merit Medical Systems Competitors $1.51 billion $110.21 million -196.40

Merit Medical Systems’ rivals have higher revenue and earnings than Merit Medical Systems. Merit Medical Systems is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Profitability

This table compares Merit Medical Systems and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Merit Medical Systems 2.37% 10.01% 6.01%
Merit Medical Systems Competitors -73.41% -76.87% -18.11%

Volatility and Risk

Merit Medical Systems has a beta of 1.33, indicating that its stock price is 33% more volatile than the S&P 500. Comparatively, Merit Medical Systems’ rivals have a beta of 0.77, indicating that their average stock price is 23% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent recommendations for Merit Medical Systems and its rivals, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Merit Medical Systems 0 0 12 0 3.00
Merit Medical Systems Competitors 531 1979 3871 133 2.55

Merit Medical Systems presently has a consensus price target of $49.73, suggesting a potential downside of 3.44%. As a group, “Surgical & medical instruments” companies have a potential upside of 4.00%. Given Merit Medical Systems’ rivals higher possible upside, analysts clearly believe Merit Medical Systems has less favorable growth aspects than its rivals.

Insider & Institutional Ownership

96.0% of Merit Medical Systems shares are owned by institutional investors. Comparatively, 46.6% of shares of all “Surgical & medical instruments” companies are owned by institutional investors. 5.2% of Merit Medical Systems shares are owned by company insiders. Comparatively, 15.7% of shares of all “Surgical & medical instruments” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Merit Medical Systems beats its rivals on 8 of the 13 factors compared.

About Merit Medical Systems

Merit Medical Systems, Inc. designs, develops, manufactures, and markets various disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates through Cardiovascular and Endoscopy segments. It provides various peripheral intervention products, including access, angiography, intervention, and drainage and biopsy products to alleviate patients suffering from peripheral vascular and non-vascular diseases; and cardiac intervention products to aid in the treatment of various cardiac conditions specific to interventional cardiology and electrophysiology, including cardiac rhythm management and lead management. The company also offers cardiovascular and critical care products comprising infection prevention and safety, and fluid management and monitoring devices. In addition, it provides interventional oncology and spine products, such as vertebral compression fractures; tumor ablation systems; inflation syringes; microspheres for treating hypervascularized tumors and liver cancer; polyvinyl alcohol particles to treat hypervascularized tumors; and microcatheters for the controlled and selective infusion of diagnostic, embolic, or therapeutic agents into vessels. Further, the company offers endoscopy products, such as non-vascular stents, esophageal stents, biliary stent systems, esophageal balloon dilators, inflation devices, and guide wires; and kits and accessories for endoscopy and bronchoscopy procedures. Additionally, it provides coated tubes and wires; and microelectromechanical systems sensor components. The company sells its products to hospitals and clinic-based physicians, technicians, and nurses through its direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. Merit Medical Systems, Inc. was founded in 1987 and is headquartered in South Jordan, Utah.